STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVA
  4. [Form 4] Enova International, Inc. Insider Trading Activity

Enova (NYSE: ENVA) chair sells option shares in 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enova International, Inc. (ENVA) reported that Executive Chairman David Fisher exercised and sold company stock in paired transactions. On August 25 and 26, 2026, he exercised non-qualified stock options for a total of 18,569 shares of common stock at an exercise price of $20.73 per share and acquired the same number of common shares. On those same dates, he sold all 18,569 shares in open-market transactions at weighted average prices of $244.01 (range $241.46–$251.20) and $239.16 (range $236.29–$244.93) per share, pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026. The exercised options, which were granted in tandem with a limited stock appreciation right, carry an exercise price of $20.73 and were scheduled to expire on February 11, 2027.

Positive

  • None.

Negative

  • None.
Insider Fisher David
Role Executive Chairman
Sold 18,569 shs ($4.49M)
Approx. gross sale proceeds $4.49M
Approx. exercise cost $385K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) with limited SAR F4, F5, F6 9,078 $0.00 $0.00
Exercise Common stock, par value $0.00001 per share 9,078 $20.73 $188K
Sale Common stock, par value $0.00001 per share F1, F3 9,078 $239.1631 $2.17M
Exercise Non-Qualified Stock Option (right to buy) with limited SAR F4, F5, F6 9,491 $0.00 $0.00
Exercise Common stock, par value $0.00001 per share 9,491 $20.73 $197K
Sale Common stock, par value $0.00001 per share F1, F2 9,491 $244.0104 $2.32M
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 166,113 shares (Direct); Common stock, par value $0.00001 per share — 306,444 shares (Direct)
Footnotes (6)
  1. F1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.
  2. F2. This transaction was executed in multiple trades at prices ranging from $241.46 to $251.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
  3. F3. This transaction was executed in multiple trades at prices ranging from $236.29 to $244.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
  4. F4. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
  5. F5. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
  6. F6. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Options exercised on August 25, 2026 9,491 shares at $20.73 per share Non-qualified stock options exercised into ENVA common stock
Shares sold on August 25, 2026 9,491 shares at $244.0104 per share Open-market sale at weighted average price (range $241.46–$251.20)
Options exercised on August 26, 2026 9,078 shares at $20.73 per share Non-qualified stock options exercised into ENVA common stock
Shares sold on August 26, 2026 9,078 shares at $239.1631 per share Open-market sale at weighted average price (range $236.29–$244.93)
Total options exercised 18,569 shares Aggregate ENVA shares from option exercises on August 25–26, 2026
Option exercise price $20.73 per share Exercise price of non-qualified stock options with limited SAR
Option expiration date February 11, 2027 Expiration date for the non-qualified stock options exercised
Rule 10b5-1 plan adoption date January 30, 2026 Date David Fisher adopted the trading plan governing these sales
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
limited stock appreciation right ("SAR") financial
"The limited stock appreciation right ("SAR") and employee stock option were granted"
Change in Control regulatory
"only during the period beginning on the first day following the date that a "Change in Control""
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Offer Value Per Share financial
"The "Offer Value Per Share" means the average selling price of Issuer's common stock"
tender offer or exchange offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"

FAQ

What insider transactions were reported for ENVA on this Form 4?
Executive Chairman David Fisher reported exercising non-qualified stock options for 18,569 shares of Enova International (ENVA) common stock at an exercise price of $20.73 per share and selling the resulting 18,569 shares in open-market transactions on August 25 and 26, 2026.

At what prices did David Fisher sell ENVA shares in these transactions?
David Fisher sold 9,491 shares at a weighted average price of $244.01 per share (range $241.46–$251.20) and 9,078 shares at a weighted average price of $239.16 per share (range $236.29–$244.93). All figures relate to Enova International (ENVA) common stock.

What was the option exercise price in the ENVA Form 4 transactions?
The non-qualified stock options that David Fisher exercised for Enova International (ENVA) shares had an exercise price of $20.73 per share. He exercised options for 9,491 shares on August 25, 2026, and 9,078 shares on August 26, 2026.

Were the ENVA insider sales made under a Rule 10b5-1 trading plan?
Yes. The Form 4 states that the sales were effected pursuant to David Fisher’s Rule 10b5-1 trading plan adopted on January 30, 2026, and the filing’s Rule 10b5-1 checkbox is affirmatively marked.

How many ENVA shares did David Fisher sell in total in this Form 4?
David Fisher sold a total of 18,569 shares of Enova International (ENVA) common stock, consisting of 9,491 shares sold on August 25, 2026, and 9,078 shares sold on August 26, 2026, in open-market transactions.

What are the key terms of the options and SAR reported for ENVA?
The filing describes non-qualified stock options with a $20.73 exercise price, expiring on February 11, 2027, granted in tandem with a limited stock appreciation right that becomes exercisable following a defined Change in Control and related qualifying Offer for Enova International (ENVA).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fisher David
(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600
(Street)
CHICAGO ILLINOIS 60604
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00001 per share08/25/2026M9,491A$20.73315,935D
Common stock, par value $0.00001 per share08/25/2026S(1)9,491D$244.0104(2)306,444D
Common stock, par value $0.00001 per share08/26/2026M9,078A$20.73315,522D
Common stock, par value $0.00001 per share08/26/2026S(1)9,078D$239.1631(3)306,444D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(4)(5)$20.7308/25/2026M9,491 (6)02/11/2027Common stock; par value $0.00001 per share9,491$0175,191D
Non-Qualified Stock Option (right to buy) with limited SAR(4)(5)$20.7308/26/2026M9,078 (6)02/11/2027Common stock; par value $0.00001 per share9,078$0166,113D
Explanation of Responses:
1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on January 30, 2026.
2. This transaction was executed in multiple trades at prices ranging from $241.46 to $251.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
3. This transaction was executed in multiple trades at prices ranging from $236.29 to $244.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
4. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
5. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
6. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
/s/ Sean Rahilly, as attorney in fact08/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR